热门资讯> 正文
Akari Therapeutics宣布临时首席执行官雇佣合同
2024-06-05 20:53
- Akari Therapeutics (NASDAQ:AKTX) in follow up to the May 1st announcement that Samir R. Patel, has assumed the role of Interim President & CEO, provides detail of Dr. Patel’s employment compensation.
- Dr. Patel’s employment contract reaffirms his desire to align his success directly with the success of the company's shareholders.
- Dr. Patel will be compensated solely with equity, aligning his interests with Akari's shareholders.
- Dr. Patel's employment contract includes no cash compensation, severance package or performance bonuses.
More on Akari Therapeutics
- Akari gains despite leadership change amid portfolio shakeup
- Financial information for Akari Therapeutics
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
